SCHEMBL2197680

SCHEMBL2197680

CCOC(=O)c1c(-c2cncnc2)n[nH]c1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.40
HPGDS O60760 1/20 0.37
ADORA3 P0DMS8 3/20 0.36
KDM4E B2RXH2 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
HTT P42858 2/20 0.36
MAPK10 P53779 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200905 0.85 CDK5 (0.46) HPGDSADORA3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL4442104 0.82 HTT (0.53) PDE4DHPGDSADORA3KDM4ESMN1; SMN2
SCHEMBL2201791 0.77 PDE4D (0.63) PDE4DADORA3KDM4ESMN1; SMN2GAA
SCHEMBL20471495 0.72 KDM4E (0.50) PDE4DKDM4ESMN1; SMN2ALDH1A1MAPT
SCHEMBL6196509 0.70 PDE4D (0.45) PDE4DADORA3KDM4EGAAALDH1A1
SCHEMBL15056281 0.69 KDM4E (0.46) PDE4DKDM4EALDH1A1MAPTLMNA
Hydrochloric Acid SCHEMBL15056842 0.68 KDM4E (0.44) PDE4DKDM4EALDH1A1MAPTLMNA
SCHEMBL30994694 0.68 MEN1 (0.59) KDM4EGAAALDH1A1NPC1MAPT
SCHEMBL24906430 0.67 KDM4E (0.43) PDE4DKDM4ESMN1; SMN2ALDH1A1MAPT
SCHEMBL3955646 0.67 HCAR2 (0.60) PDE4DKDM4EMAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 PDE4D 814/4885HPGDS 614/4885ADORA3 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.